Global Fund: Malaria, HIV, TB Deaths at Risk from Donor Cuts

Here’s a breakdown of the key information from the provided text,organized for clarity:

1. Global Fund‘s Investments & Impact (2024 & Beyond)

* Total investment (2024): $2.7 billion in ‍health systems.
* Cross-Cutting Benefits: These investments benefit areas beyond HIV, TB, and malaria.
* Strengthened Networks: Improved laboratory and diagnostic ‍networks help with:
* HIV, TB, and malaria responses.
* ⁣Detection of co-infections (hepatitis B, C, HPV).
* Testing for high-risk diseases (mpox, Ebola, Marburg, Crimean-Congo ‍hemorrhagic fever).
* Medical Oxygen: $600+ million invested in improving medical oxygen access in low/middle-income countries,⁢ notably through PSA plants ⁢(which create ‍oxygen from the atmosphere). This ⁣has dramatically increased access,now supporting neonatal care,maternal health,trauma,and surgery. (Before the pandemic, 9/10 hospitals lacked medical‍ oxygen).

2. Eighth Replenishment Drive (2025-2029)

* Launch: February ⁢2025
* Goal: Raise $18 billion.
* ⁢ Funding Cycle: ⁢ 2027-2029
* Funds Raised So Far: Approximately $700 million (from Australia, luxembourg, Norway, Spain, and ‍private donors like the Children’s Investment Fund foundation).

3. Challenges & Funding Concerns

* Donor Retreat: The US is reducing global health funding, and other traditional donors are also decreasing contributions.
* Budget cuts: The Global Fund has already cut $1.43 billion from its 2025-2026 budget.
* Further Adjustments: More budget adjustments are being made⁣ due to the funding situation.
*‍ Staffing: While no data is released, staff⁤ cutbacks are implied.

In essence, the Global Fund is making significant investments with broad⁣ health benefits, but faces a ‍challenging fundraising environment due to shifting donor priorities.